Mutations of <i>GATA3</i>, <i>PLCG2</i>, and <i>FAT1</i> were identified in both CLL/SLL and MEITL areas, but the clinical significance was unknown. The gene discussed is PLCG2; the disease is B-cell chronic lymphocytic leukemia.